Tersis Technologies, Inc, formerly International Consolidated Companies, Inc., through its subsidiary, BluDog Products LLC, sells cannabidiol (CBD) products for pets. The Company is engaged in the business of developing and marketing specialized CBD products for the pet and animal markets. Its subsidiary, AG Tech Carbon LLC, provides both technology and consulting services to bamboo and eucalyptus growers, carbon footprint reduction activists, and industry professionals.

Employees

Sector

Drug Retailers

More about the company

Market Cap	23.38K 20.78K 19.37K 17.65K 33.3K 2.25M 33.62K 235K 90.98K 1.15M 87.75K 85.85K 3.69M	P/E 2009	-23.4x	P/E 2010	-0.09x
Enterprise Value	-731K -650K -606K -552K -1.04M -70.41M -1.05M -7.34M -2.85M -35.91M -2.74M -2.69M -115M	EV / Sales 2009	3x	EV / Sales 2010	-1.71x
Free-Float	4.16%	Yield 2009 *	-	Yield 2010	-

07-20	Tersis Technologies, Inc. Announces Appointment of Vaughan B. Adnams to Chief Investment & Capital Markets Officer, Effective July 20, 2026	CI
06-04	Tersis Technologies, Inc. Announces Appointment of Scott St. John to Chief Strategic Development Officer	CI
03-04	Tersis Technologies Inc. Announces Appointment of Hugo Mijares as Chief Architectural Officer, Effective 4 March 2026	CI
21/07/21	International Consolidated Companies, Inc. completed the acquisition of SoundTech AI, Inc for $150 million	CI
14/07/21	International Consolidated Companies, Inc. executed a letter of intent to acquire SoundTech AI, Inc	CI
12/04/21	International Consolidated Companies, Inc. completed the acquisition of Blue Plant Farms LLC.	CI
20/04/18	Bludog Products LLC Forms Strategic Partnership with Natures Renewable LLC	CI
11/04/18	International Consolidated Companies, Inc. completed the acquisition of American Nutritional Products, Inc.	CI
12/03/18	International Consolidated Companies, Inc. agreed to acquire American Nutritional Products, Inc.	CI
13/11/17	International Consolidated Companies, Inc. announced that it expects to receive $100 million in funding	CI
21/06/17	International Consolidated Companies, Inc. Enters into Licensing Agreement with CBD Medicinals, LLC	CI
13/06/17	International Consolidated Companies, Inc. Enters into an Exclusive License Agreement with Brooks Kelly Research, LLC	CI
31/05/17	International Consolidated Companies, Inc. entered into a letter of intent to acquire BluDog Products LLC.	CI

09-30	Tersis Technologies Files U.S. Provisional Patent Application to Turn Waste-Derived Carbon into Energy-Storage Material	NE
09-24	Tersis Technologies Hosts Private Climate Week Salon in New York	NE
09-03	Tersis Technologies Engages DIFFRNT Developments to Lead Web Development and Digital Infrastructure	NE
09-01	Tersis Technologies and Flux Core Sign MOU to Advance Decentralized Data Centers and Sustainable AI Compute	NE
08-24	Tersis Technologies and Ameri-Green Environmental Recycling Sign MOU for First Planned U.S. Commercial Deployment of SynGenic V3 Technology	NE

Manager	Title	Age	Since
Antonio Uccello CEO	Chief Executive Officer	58	27/01/2002
Vaughan Adnams CIO	Chief Investment Officer	-	19/07/2026
Scott John PRN	Corporate Officer/Principal	-	02/06/2026

Director	Title	Age	Since
Antonio Uccello CHM	Chairman	58	27/01/2002
Cortland J. Ornburg BRD	Director/Board Member	-	-
Thomas J. Megale BRD	Director/Board Member	-	-

International Consolidated Companies Inc Share Price OTC Bulletin Board

Stocks

US4593571098

Drug Retailers

Valuation: International Consolidated Companies Inc

Latest news: International Consolidated Companies Inc

Press Releases: International Consolidated Companies Inc

Quotes and Performance

Managers and Directors: International Consolidated Companies Inc

Cannabis Product Retailers

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERNATIONAL CONSOLIDATED COMPANIES INC	+20.00%	-.--%	-	-	48.64M
JD HEALTH INTERNATIONAL INC.	-3.78%	-1.25%	-48.07%	-14.68%	14.08B
RAIA DROGASIL S.A.	+5.81%	+7.38%	+10.38%	-27.36%	6.51B
MATSUKIYOCOCOKARA & CO.	-0.71%	-3.63%	-16.66%	-7.34%	6.06B
TSURUHA HOLDINGS INC.	-1.67%	-4.89%	-11.03%	+2.13%	5.92B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-1.75%	-0.35%	-57.73%	-42.32%	5.8B
YIFENG PHARMACY CHAIN CO., LTD.	+1.30%	+5.57%	-5.44%	-20.24%	4.22B
NAHDI MEDICAL COMPANY	+0.11%	-0.38%	-24.71%	-38.45%	3.15B
COSMOS PHARMACEUTICAL CORPORATION	-0.21%	-1.51%	-25.42%	-17.83%	3.11B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+2.08%	+3.70%	+10.37%	-27.63%	3.09B
Average	+2.12%	-0.41%	-18.70%	-21.52%	5.77B
Weighted average by Cap.	-0.52%	-0.76%	-24.22%	-19.43%

	2009	2010
Net sales	10.91M 9.7M 9.04M 8.24M 15.54M 1.05B 15.69M 110M 42.47M 536M 40.96M 40.07M 1.72B	313K 279K 260K 237K 446K 30.18M 451K 3.15M 1.22M 15.39M 1.18M 1.15M 49.46M
Net income	-1.3M -1.15M -1.07M -979K -1.85M -125M -1.86M -13.01M -5.04M -63.64M -4.86M -4.76M -205M	-2.37M -2.1M -1.96M -1.79M -3.37M -228M -3.4M -23.76M -9.21M -116M -8.88M -8.69M -373M
Net Debt	666K 592K 551K 503K 948K 64.09M 957K 6.68M 2.59M 32.68M 2.5M 2.44M 105M	-755K -671K -625K -570K -1.07M -72.66M -1.09M -7.58M -2.94M -37.05M -2.83M -2.77M -119M